Iloprost
featured

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H318054

CAS#: 78919-13-8

Description: Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. This damages the tissues and causes high blood pressure. Iloprost works by opening (dilating) the blood vessels to allow the blood to flow through again. Note: This product is supplied as acetone solution (10 mg /mL)

Chemical Structure

img
Iloprost
CAS# 78919-13-8
Instruction

Theoretical Analysis

Hodoodo Cat#: H318054
Name: Iloprost
CAS#: 78919-13-8
Chemical Formula: C22H32O4
Exact Mass: 360.23
Molecular Weight: 360.487
Elemental Analysis: C, 73.30; H, 8.95; O, 17.75

Price and Availability

Size Price Availability Quantity
5mg USD 850 Ready to ship
250mg USD 7950 2 Weeks
500mg USD 12950 2 weeks
1g USD 18950 2 weeks
Bulk inquiry

Synonym: ZK 36374; ZK-36374; ZK36374; ZK 00036374; BAY Q6256; Iloprost, Endoprost, Ilomedin, Ciloprost, Ventavis, CHEMBL494

IUPAC/Chemical Name: (5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid

InChi Key: HIFJCPQKFCZDDL-ACWOEMLNSA-N

InChi Code: InChI=1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1

SMILES Code: O=C(O)CCC/C=C1C[C@@]2([H])C[C@@H](O)[C@H](/C=C/[C@@H](O)C(C)CC#CC)[C@@]2([H])C\1

Appearance: Clear solution in acetone (white Oily or waxy solid in pure form)

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in ethyl acetate (supplied pre-dissolved 10 mg/ml)

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 360.49 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Santos-Martínez LE, Moreno-Ruiz LA, Jiménez-Santos M, Olmos-Temois SG, Bojorquez-Guerrero LA, Baranda-Tovar FM. [Clinical utility of inhaled iloprost in pulmonary arterial hypertension]. Arch Cardiol Mex. 2014 Jul-Sep;84(3):202-10. doi: 10.1016/j.acmx.2014.01.003. Epub 2014 Jul 4. Review. Spanish. PubMed PMID: 25001057.

2: Mulligan C, Beghetti M. Inhaled iloprost for the control of acute pulmonary hypertension in children: a systematic review. Pediatr Crit Care Med. 2012 Jul;13(4):472-80. doi: 10.1097/PCC.0b013e31822f192b. Review. PubMed PMID: 21926655.

3: Ewert R, Gläser S, Bollmann T, Schäper C. Inhaled iloprost for therapy in pulmonary arterial hypertension. Expert Rev Respir Med. 2011 Apr;5(2):145-52. doi: 10.1586/ers.11.14. Review. PubMed PMID: 21510725.

4: John J, Palevsky H. Clinical pharmacology and efficacy of inhaled iloprost for the treatment of pulmonary arterial hypertension. Expert Rev Clin Pharmacol. 2011 Mar;4(2):197-205. doi: 10.1586/ecp.10.136. Review. PubMed PMID: 22115402.

5: Piaggesi A, Vallini V, Iacopi E, Tedeschi A, Scatena A, Goretti C, Rizzo L. Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus. Minerva Cardioangiol. 2011 Feb;59(1):101-8. Review. PubMed PMID: 21285935.

6: Kharazov AF. [Randomized placebo-controlled studies of iloprost in treatment of lower limb critical ischaemia]. Angiol Sosud Khir. 2010;16(3):27-33. Review. Russian. PubMed PMID: 21280291.

7: Chen YF, Jowett S, Barton P, Malottki K, Hyde C, Gibbs JS, Pepke-Zaba J, Fry-Smith A, Roberts J, Moore D. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation. Health Technol Assess. 2009 Oct;13(49):1-320. doi: 10.3310/hta13490. Review. PubMed PMID: 19863849.

8: Erre GL, Passiu G. Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis. Reumatismo. 2009 Apr-Jun;61(2):90-7. Review. PubMed PMID: 19633795.

9: Olschewski H. Inhaled iloprost for the treatment of pulmonary hypertension. Eur Respir Rev. 2009 Mar;18(111):29-34. doi: 10.1183/09059180.00011111. Review. PubMed PMID: 20956120.

10: Krug S, Sablotzki A, Hammerschmidt S, Wirtz H, Seyfarth HJ. Inhaled iloprost for the control of pulmonary hypertension. Vasc Health Risk Manag. 2009;5(1):465-74. Review. PubMed PMID: 19475782; PubMed Central PMCID: PMC2686263.

11: Hachulla E, Launay D, Hatron PY. [Iloprost for the treatment of systemic sclerosis]. Presse Med. 2008 May;37(5 Pt 2):831-9. Epub 2007 Nov 26. Review. French. PubMed PMID: 18035518.

12: Hsu HH, Rubin LJ. Iloprost inhalation solution for the treatment of pulmonary arterial hypertension. Expert Opin Pharmacother. 2005 Sep;6(11):1921-30. Review. PubMed PMID: 16144511.

13: Baker SE, Hockman RH. Inhaled iloprost in pulmonary arterial hypertension. Ann Pharmacother. 2005 Jul-Aug;39(7-8):1265-74. Review. PubMed PMID: 15976392.

14: de Donato G, Gussoni G, de Donato G. Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful? Chir Ital. 2004 Nov-Dec;56(6):769-80. Review. PubMed PMID: 15771029.

15: Minder S, Fischler M, Muellhaupt B, Zalunardo MP, Jenni R, Clavien PA, Speich R. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension. Eur Respir J. 2004 Oct;24(4):703-7. Review. PubMed PMID: 15459152.

16: Wilhelm W, Grundmann U. [Iloprost. Pharmacology and clinical application during surgery]. Anaesthesist. 2004 Aug;53(8):745-7. Review. German. PubMed PMID: 15241524.

17: Aigner N, Meizer R, Stolz G, Petje G, Krasny C, Landsiedl F, Steinboeck G. Iloprost for the treatment of bone marrow edema in the hindfoot. Foot Ankle Clin. 2003 Dec;8(4):683-93. Review. PubMed PMID: 14719835.

18: Matthes J, Mathen F, Herzig S, Wassermann K. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost]. Dtsch Med Wochenschr. 2001 May 25;126(21):631-7. Review. German. PubMed PMID: 11413752.

19: Pope J, Fenlon D, Thompson A, Shea B, Furst D, Wells G, Silman A. Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis. Cochrane Database Syst Rev. 2000;(2):CD000953. Review. PubMed PMID: 10796395.

20: Cappelli R, Bicchi M, Arrigucci S, Boschi S, Guerrini M, Forconi S. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency]. Minerva Cardioangiol. 1999 Mar;47(3):81-8. Review. Italian. PubMed PMID: 10389449.